Europe

View All
April 25, 2023 Off

Sanofi launches Avaxim Junior in the UK for Active Immunisation Against Infection Caused by the Hepatitis A Virus in 1 – 15 y.o.

By Dino Mustafić

Sanofi announced Tuesday the launch of AVAXIM® Junior in the UK, an inactive hepatitis A vaccine indicated for use in children aged 12 months to 15 years inclusive to prevent...

USA

View All
November 14, 2022 Off

Moderna’s biovalent booster candidates meet primary endpoint of superiority against Omicron variants in trai

By Dino Mustafić

Moderna said Monday that both of its bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger a superior antibody response compared to a booster dose of mRNA-1273, the Company's prototype vaccine,...

My Pharmaceutical

View All
April 13, 2022 Off

Allergan’s BOTOX Cosmetic Celebrates 20th Birthday

By Author

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.

April 13, 2022 Off

EMA and the EUnetHTA 21 consortium set priorities for their collaboration

By Author

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a  joint work plan until 2023....

April 4, 2022 Off

Sanofi Launches First-In-Pharma Diversity, Equity & Inclusion Board

By Author

Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors....